Pancreatitis post-colangiopancreatografía retrógrada endoscópica

Abstract

Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis is the most common and serious complication of ERCP, its incidence varies from 8-15%; diagnosis is established with abdominal pain and elevated pancreatic enzymes (> 3 times upper limit value) the next 24 hours posterior to ERCP. There are some risk factors associated to patient (female gender, young age, previous post-ERCP pancreatitis, suspected of Oddi dysfunction) and risk factors related to procedure (difficult bile duct cannulation, ampullectomy, main pancreatic duct opacification, multiple attempts of cannulation, sphinc- teroplasty). Methods proven to reduce post-ERCP pancreatitis are pharmacological (rectal non-steroidal anti-inflammatory drugs) and non-pharmacological (Ringer lactate hyperhydration, early precut, pancreatic stent). It is very important to evalu- ate risk factors in order to apply necessary measures to reduce the incidence. Keywords: